Skip to content
Sleep Study Clinical Trials

Atlanta, Georgia

Sleep disorder clinical trials in Atlanta, GA

18 sleep disorder studies are recruiting participants at sites in Atlanta as of November 16, 2026, according to ClinicalTrials.gov. Sleep Study Clinical Trials can help you understand your options and connect with a study team.

Call (888) 927-8925
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Atlanta at a glance

  • 18 studies are recruiting at a site in Atlanta.
  • By phase: Phase 2 (4), Phase 2/3 (4), Phase 3 (7), No phase (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (13), university, hospital or other (4), government (1).
  • By research area: Narcolepsy (9), Insomnia (6), Sleep Apnea (3).
  • Most recent update to one of these records: November 13, 2026.

Insomnia studies recruiting in Atlanta

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Agile Clinical Research Trials, LLC
    Registry record
    NCT06559306 · updated
  2. The Effect of a Daily Magnesium and Melatonin Supplement on Sleep Quality in People With Nighttime Leg Cramps

    • No phase
    • Ages 40 to 75
    • All sexes
    Sponsor
    StudySetGo
    Study site
    Remote participation (home-based, no site visits)
    Registry record
    NCT07651514 · updated
  3. Multi-center Trial to Improve Nocturia and Sleep in Older Adults

    • No phase
    • Ages 60 and older
    • All sexes
    Sponsor
    Atlanta VA Medical Center
    Study site
    Atlanta VAHCS
    Registry record
    NCT06110091 · updated
  4. Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Emory University
    Study site
    Emory University
    Registry record
    NCT07336277 · updated
  5. Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Registry record
    NCT06568367 · updated
  6. Progesterone in Gender Affirming Hormone Therapy Study

    • Phase 2
    • Ages 18 to 60
    • Male participants
    Sponsor
    Emory University
    Study site
    Emory Transgender Clinic
    Registry record
    NCT06807580 · updated

Source: ClinicalTrials.gov. Data processed . See every insomnia study recruiting in Atlanta, GA on ClinicalTrials.gov.

Sleep apnea studies recruiting in Atlanta

  1. AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Novo Nordisk A/S
    Study site
    NeuroTrials Research, Inc.
    Registry record
    NCT07571109 · updated
  2. AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Novo Nordisk A/S
    Study site
    Conquest Research
    Registry record
    NCT07571005 · updated
  3. Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Study site
    Emory University Hospital Midtown
    Registry record
    NCT05350332 · updated

Source: ClinicalTrials.gov. Data processed . See every sleep apnea study recruiting in Atlanta, GA on ClinicalTrials.gov.

Narcolepsy studies recruiting in Atlanta

  1. A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Harmony Biosciences Management, Inc.
    Study site
    Neurotrials Research Inc
    Registry record
    NCT07675135 · updated
  2. A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

    • Phase 2/3
    • Ages 18 to 71
    • All sexes
    Sponsor
    Takeda
    Study site
    Takeda Site 6
    Registry record
    NCT07646678 · updated
  3. A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

    • Phase 2/3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Centessa Pharmaceuticals (UK) Limited
    Study site
    Atlanta, Georgia
    Registry record
    NCT07598708 · updated
  4. A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

    • Phase 2/3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigational Site
    Registry record
    NCT06767683 · updated
  5. A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Takeda
    Study site
    Takeda Site 32
    Registry record
    NCT06952699 · updated
  6. A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

    • Phase 3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigational Site
    Registry record
    NCT07540897 · updated
  7. A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Centessa Pharmaceuticals (UK) Limited
    Study site
    Atlanta, Georgia
    Registry record
    NCT06752668 · updated
  8. A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Centessa Pharmaceuticals (UK) Limited
    Study sites
    Atlanta, Georgia · Stockbridge, GA
    Registry record
    NCT07096674 · updated
  9. A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

    • Phase 2/3
    • Ages 16 to 70
    • All sexes
    Sponsor
    Takeda
    Study site
    Neurotrials Research
    Registry record
    NCT05816382 · updated

Source: ClinicalTrials.gov. Data processed . See every narcolepsy study recruiting in Atlanta, GA on ClinicalTrials.gov.

Ask about studies near Atlanta

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Sleep Study Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-8925

or send a short form

How should we reach you?

Call